Clinical Trials Browser

Interventional × Quillaja Saponins × 90 days × Clear all

NCT06741072 2026-04-21

BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting Solid Organ Transplants

Phase 1 Suspended

Renal Insufficiency, Chronic